23
Participants
Start Date
September 30, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
September 30, 2015
TAS-205
"* Single-dose phase: 3 steps (low dose, middle dose or high dose group), 5 patients/step, single oral administration after meals~* Multiple-dose phase: 3 steps (low dose, middle dose or high dose group), 5 patients/step (the same patients between single- and multiple-dose phases), repeated oral administration for 7 days, BID after meals"
Placebo
"* Single-dose phase: 3steps (low dose, middle dose or high dose group), 2 patients/step, single oral administration after meals~* Multiple-dose phase: 3 steps (low dose, middle dose or high dose group), 2 patients/step (the same patients between single- and multiple-dose phases), repeated oral administration for 7 days, BID after meals"
National Center of Neurology and Psychiatry, Tokyo
Taiho Pharmaceutical Co., Ltd.
INDUSTRY